Enzyme substrate inhibitors block the interaction between enzymes and their substrates, giving therapies for enzyme-related illness and metabolic disorders. Glycosidase inhibitors, by blocking the break down of carbohydrates, deal therapy choices for diabetes and various other metabolic conditions.